Trial reportBJS open2026
Robotic gastric Roux-en-Y bypass with or without concomitant cholecystectomy: pilot open label randomized trial.
Trial report in BJS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04324515 (Pilot Open Randomized Controlled Trial Comparing Patients Undergoing Robotic Gastric Bypass With or Without Concomitant Cholecystectomy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pilot Open Randomized Controlled Trial Comparing Patients Undergoing Robotic Gastric Bypass With or Without Concomitant Cholecystectomy
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDebate continues about the need for prophylactic concomitant cholecystectomy (CC) at the time of Roux-en-Y gastric bypass (RYGB). The concerns over higher complication rates should be balanced against the risk of future biliary events. This pilot trial compared RYGB with CC to RYGB alone in patients without preoperative gallstones to inform a future large randomized trial.
methodsEligible patients without gallstones scheduled to undergo RYGB were randomized before surgery using a 1 : 1 allocation ratio. Surgeons and patients were not blinded. The primary outcome was a composite of intraoperative adverse events and 30-day postoperative complications. In addition, feasibility (time to enrolment, completion of follow-up) was added as a co-primary endpoint after the study started, driven by prolonged enrolment times and independent of trial results. Secondary outcomes included late complications, biliary events, length of operation, length of hospital stay, and quality of life.
resultsIn all, 96 patients were randomized between July 2018 and January 2023, and 95 were included in the full analysis due to one withdrawal. There were 49 and 46 patients in the RYGB with and without CC arms, respectively. The feasibility endpoint was met with regard to the completion of follow-up (95/95, 100% at 1 month; 88/95 93% at 18 months), but not the time to enrolment (21 patients randomized per year). The composite outcome of intraoperative and postoperative complications occurred in 44.9% and 26.1% of patients with and without CC, respectively (difference 18.8%; 95% confidence interval (c.i.) -0.6 to 36.8; P = 0.098). Patients with CC had a higher early comprehensive complication index score (mean 6.09 versus 2.06; difference 4.03; 95% c.i. 0.23 to 7.83; P = 0.047). Late (> 30 days) complications, length of hospital stay, and quality of life were similar between the two groups. During the 18-month follow-up, biliary events occurred in 3 patients without CC (6.5%), of whom 2 required biliary intervention (4.4%) compared with 1 patient with CC (2%), with no biliary interventions required.
conclusionThe debate over performing CC during RYGB remains unresolved. The incidence of subsequent biliary interventions was low when CC was not performed. As a pilot study, this investigation sets the stage for a large randomized trial. Registration number: NCT04324515 (https://www.clinicaltrials.gov).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.